More importantly, we found that the removal of DOX results in a gradual elimination of the off-tumor hematotoxic effects of the high affinity CD38-CAR T cells, especially when DOX exposure dose was limited to 10ng/ml. This evidence concerns the gene CD38 and neoplasm.